ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Abstract Number: 1976
    Magnetic Resonance Imaging-Assessment Of Early Response To Certolizumab Pegol In Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase IIIb Study Applying Magnetic Resonance Imaging At Week 0, 1, 2, 4, 8 and 16
  • Abstract Number: 302
    Maintenance Of Efficacy and Safety Of Ustekinumab In Patients With Active Psoriatic Arthritis Despite Prior Conventional Nonbiologic and Anti-TNF Biologic Therapy:  1‑year Results Of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial
  • Abstract Number: 1570
    Maintenance Therapy With Taclorimus and Mizoribine Pulse In SLE
  • Abstract Number: 750
    Maintenance Treatment In Childhood Granulomatosis With Polyangiitis
  • Abstract Number: 195
    Major Cost Savings Associated With Reduced Biologic Dosing Frequency In Inflammatory Arthritis
  • Abstract Number: 327
    Major Differences In The Pattern Of Joint Swelling and Tenderness In a Large Psoriatic Arthritis Cohort – Results From An Exploratory Hierarchical Cluster Analysis
  • Abstract Number: 1879
    Major Histocompatibility Complex Class I Molecules Contribute To Behçet’s Disease Risk Through Both Innate and Adaptive Immune Interactions
  • Abstract Number: 2504
    Male Children With Higher SLE Disease Activity In An US Cohort
  • Abstract Number: 719
    Mammalian Target Of Rapamycin (mTOR) Skews T Cell Lineage Development In Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 362
    Management Of Hyperlipidemia In Patients With RA: Results From The Corrona Certain Study
  • Abstract Number: 2807
    Management Of Vertebral Osteomyelitis: A Randomized Clinical Trial Comparing 6 Versus 12 Weeks Of Antibiotic Treatment
  • Abstract Number: 861
    Many Gout Patients Treated By Rheumatologists Do Not Meet Established Treatment Goals Despite Long-Term Urate Lowering Therapy: Results Of a Gout Patient Encounter Survey
  • Abstract Number: 1025
    Mapping The Health Assessment Questionnaire On a Preference Based Utility Measure In a Large Canadian Rheumatoid Arthritis Cohort: Results From The Ontario Best Practices Research Initiative
  • Abstract Number: 1704
    Mapping The Shared and Distinct HLA Alleles For Seropositive and Seronegative Rheumatoid Arthritis
  • Abstract Number: 269
    Marked Improvement In Patient Reported Outcomes Of Children With Active Systemic Juvenile Idiopathic Arthritis With Canakinumab Treatment – Results Of The Phase III Program
  • Abstract Number: 2892
    Masp-1/3 Deficient MRL/Lpr Mice Lack The Alternative Complement Pathway Activation and Are Protected From Development Of Lupus-Like Glomerulonephritis
  • Abstract Number: 1900
    Mass Spectrometry-Based Salivary Proteomics For The Discovery Of Novel Diagnostic Biomarkers For Primary Sjögren’s Syndrome and Its Clinical Subsets
  • Abstract Number: 2500
    Mast Cells Are a Major Source Of IL-17 In Synovium and Extra-Articular Tissues In Spondyloarthritis Related Diseases
  • Abstract Number: 2834
    Maternal data Analysis Of The French Registry Of 205 Cases Of Immune Congenital Heart Block (neonatal lupus)
  • Abstract Number: 1274
    Maternal Vitamin D, Fetal C-Reactive Protein and Brain Natriuretic Peptide Associate With The Development and Morbidity Of Cardiac Neonatal Lupus
  • Abstract Number: 1331
    Mathematical Model To Predict The Early Responders In a Monocentric Cohort Of Patients With Rheumatoid Arthritis Treated By Anti TNF-Alpha
  • Abstract Number: 1677
    May Giant Cell Arteritis Be Characterized By Different Clinical Entity and Long-Term Outcome?
  • Abstract Number: 1525
    Measurement Of Lateral Spinal Flexion and Schober Is Sufficient To Be Informed About Spinal Mobility In Patients With Ankylosing Spondylitis: 12-Year OASIS Results
  • Abstract Number: 1003
    Measuring Economic Value of Morning Stiffness; Consistency Over 1 Year
  • Abstract Number: 2122
    Mechanical Back Pain Demonstrates Better Response To Celecoxib Than Acetaminophen Despite Lack Of MRI-Defined Inflammatory Changes In The Spine
  • Abstract Number: 1295
    Mechanisms For Fostamatinib-Induced Blood Pressure Elevation
  • Abstract Number: 974
    Medical Student Perceptions Of Point-Of-Care Ultrasound In Musculoskeletal Education
  • Abstract Number: 2678
    Medically Significant Infections Are Increased In Patients With Juvenile Idiopathic Arthritis Treated With Etanercept. Results From The British Society For Paediatric and Adolescent Rheumatology Etanercept Cohort Study
  • Abstract Number: 2849
    Medication Adherence and Healthcare Costs Among Patients With Fibromyalgia: Combination Medication Versus Duloxetine, Pregabalin, and Milnacipran Initiators
  • Abstract Number: 210
    Medication Adherence In Patients With Gout: A Systematic Review
  • Abstract Number: 105
    Medication Use With Denosumab (Prolia®) In a Large Claims Database In The United States
  • Abstract Number: 1519
    Meeting The ACR 2010 Fibromyalgia Criteria Worsens Disease Activity and Quality Of Life In Patients With Axial Spondyloarthritis Treated With Infliximab
  • Abstract Number: 536
    Membrane-Bound TNF Drives Axial and Peripheral Inflammation and Pathologic New Bone Formation
  • Abstract Number: 235
    Meniscal Extrusion Is a Better Predictor Of Radiographic Osteoarthritis Change Over Ten Years Compared To Cartilage Volume Loss
  • Abstract Number: 373
    Menopause Occurs Earlier and Is An Independent Risk Factor For Osteoporosis In Women With Rheumatoid Arthritis
  • Abstract Number: 718
    Mesenchymal Stem Cells and Skin Fibroblasts Both Suppress Early Steps In T Cell Activation In a Nitric-Oxide Dependent Manner
  • Abstract Number: 89
    Meta-Analysis of Randomized Controlled Trials Assessing the Effects of Vitamin D Supplementation On Skeletal Muscle Strength
  • Abstract Number: 2875
    Metabolic Profiles of Synovial Fibroblasts
  • Abstract Number: 2757
    Metabolomics For The Identification Of Urinary Biomarkers In Knee Osteoarthritis Progression
  • Abstract Number: 1332
    Metaflammation, PEDF and Chemerin: Potential Systemic Factors Which Link Obesity To Response To Therapy In Early Rheumatoid Arthritis
  • Abstract Number: 1018
    Methodology Of Determining An Appropriate Look-Back Period To Identify Autoimmune Rheumatic Disease In a Study Of Post-Myocardial Infarction Mortality
  • Abstract Number: 2181
    Methotrexate and Infliximab With Or Without Zoledronic Acid Improve Disease Activity and Prevent Damage Progression In Chronic Nonbacterial Osteomyelitis
  • Abstract Number: 2688
    Methotrexate Dose Has Minimal Effects On Methotrexate-Related Toxicity In Patients With Early Rheumatoid Arthritis Treated In Combination With Adalimumab – Results Of Concerto Trial
  • Abstract Number: 797
    Methotrexate Exposure Assessment In Routine Clinical Rheumatology Practice: Effect Of Dosing and Route Of Administration On Polyglutamate Levels
  • Abstract Number: 1317
    Methotrexate Optimization (ie introduction during the first 3 months and with dose escalation at 6 months at least at 20mg/w or 0.3mg/kg/w) Is Associated With Better Clinical Outcomes In Daily Practice: Results From The Espoir Cohort
  • Abstract Number: 792
    Methotrexate Polyglutamates in Erythrocytes Are Associated With Lower Disease Activity in Juvenile Idiopathic Arthritis Patients
  • Abstract Number: 1640
    Methotrexate Treatment Affects Effector, But Not Regulatory T Cells in Juvenile Idiopathic Arthritis
  • Abstract Number: 482
    Methotrexate Use At Infliximab Initiation and Impact On Treatment Outcomes: An Analysis From A Canadian Registry
  • Abstract Number: 1108
    Methylphenidate Improves Concentration, Energy and Mood In Fibromyalgia
  • Abstract Number: 2039
    Micro and Nanoparticles As Possible Causative-Prognostic Co-Factors Of Mixed Cryoglobulinemia Syndrome
  • Abstract Number: 148
    Microarray Analysis Of  Synovial Specimen of Early Human (CHECK) and Experimental Osteoarthritis to Identify Pathways and Processes Associated with Pathology
  • Abstract Number: 875
    Microrna Expression Profiles Associated With Response To Adalimumab and Methotrexate Versus Methotrexate: A Placebo-Controlled Clinical Trial
  • Abstract Number: 1161
    Microrna-155 As a Proinflammatory Regulator via SHIP-1 Down-Regulation In Acute Gouty Arthritis
  • Abstract Number: 2738
    Microrna-Mediated Regulation Explains Allelic Risk Of TLR7 Variant Predisposing To Systemic Lupus Erythematosis
  • Abstract Number: 2595
    Microvascular Abnormalities In Patients With Early Systemic Sclerosis: Less Severe Morphological Changes Compared To Patients With Definite Disease
  • Abstract Number: 2277
    Midcarpal Joint Effusion Is As Common As Radiocarpal Joint Effusion In Swollen Wrists Of Patients With Rheumatoid Arthritis
  • Abstract Number: 2643
    Midkine Is a Novel Prognostic Factor In Patients With Vasculitis Syndrome
  • Abstract Number: 130
    Mindfulness Is Associated With Psychological Symptoms, Self-Efficacy and Quality Of Life Among Patients With Fibromyalgia
  • Abstract Number: 688
    Minimal Clinically Important Investigations In Systemic Sclerosis
  • Abstract Number: 944
    Mir-125a: A Novel Regulator Of IL-6 and TLR Driven Pathways In RA Pathogenesis
  • Abstract Number: 2860
    Mir-26a, Mir-30b and HER2: New Players On Lupus Nephritis Pathogenesis
  • Abstract Number: 2423
    Mir-27b As Biomarker and Regulator Of IL-6R Pathway In Resistant Rheumatoid Arthritis Monocyte
  • Abstract Number: 941
    Mir-34a In Rheumatoid Arthritis: Characterisation Of Elevated Synovial Expression and Association With Treatment Resistance
  • Abstract Number: 1846
    Mitochondrial Dysfunction Induces An Inflammatory, Tissue-Degrading, and Angiogenic Response In Normal Human Synoviocytes
  • Abstract Number: 1316
    MMP3 As a Predictor Identifying a Subgroup Of Rheumatoid Patients Who Are Successfully Treated With Methotrexate (MTX) Alone But Still Subject To Radiographic Progression
  • Abstract Number: 1419
    Mode Of Action Change Not Necessary After Failing The First Tumornecrosisfactor Inhibitor: Preliminary Results Of a Randomized Controlled Trial
  • Abstract Number: 1204
    Model-Based Pharmacokinetics Of Canakinumab and Pharmacodynamics Of IL-1Beta Binding In Cryopyrin Associated Periodic Syndromes, a Step Towards Personalized Medicine
  • Abstract Number: 1024
    Modeling The Benefit Risk Profiles Of a New Janus Kinase Inhibitor Tofacitinib Compared Tottumour Necrosis Factor Inhibitor Biologic Treatments Incorporating Conjoint Derived Patient Preference Weights
  • Abstract Number: 1931
    Models Of Care For Arthritis: Drivers, Facilitators and Barriers To Their Development and Implementation
  • Abstract Number: 2601
    Modified Rodnan Ultrasound Skin Score:  An Ultrasound Skin Scoring Approach In Systemic Sclerosis
  • Abstract Number: 147
    Modular Analysis Of In Peripheral Blood Gene Expression In Rheumatoid Arthritis Captures Reproducible Gene Expression Changes In TNF Responders
  • Abstract Number: 2563
    Modulating Myofibroblast Transition Of Human Scleroderma Fibroblasts Through Inhibition Of Rho Guanine Nucleotidase-Regulated Gene Transcription
  • Abstract Number: 1172
    Molecular Characterisation Of The Killer Cell Immunoglobulin-Like Receptor 3DL2 Binding To Aberrant HLA-B27 Heavy Chains In Spondyloarthritis
  • Abstract Number: 2702
    Molecular Pathogenesis and Genetics Of Tartrate-Resistant Acid Phosphatase Deficiency In Systemic Lupus Erythematosus
  • Abstract Number: 2223
    Monitoring Of Active Matrix Metalloproteinase-3 Using
  • Abstract Number: 576
    Monitoring Of Opportunistic Virus Infections In Systemic Lupus Erythematosus
  • Abstract Number: 1223
    Monitoring Osteoporosis Therapy: Can FRAX Help To Assess Success Or Failure In Achieving Treatment Goals?
  • Abstract Number: 2784
    Mononeuritis Multiplex Predicts The Need For Immunosuppressive Or Immunomodulatory Drugs For Eosinophilic Granulomatosis With Polyangiitis, Polyarteritis Nodosa and Microscopic Polyangiitis Patients Without Poor-Prognosis Factors
  • Abstract Number: 858
    Monosodium Urate Crystal Induced Macrophage Inflammation Is Attenuated By Chondroitin Sulfate: Pre-Clinical Model For Gout Prophylaxis?
  • Abstract Number: 1134
    More Evidence For Breaking The ‘law Of valgus’: Imaging Evidence For Higher Prevalence and Volume Of Bone Marrow Lesions In The Medial Patellofemoral Joint
  • Abstract Number: 1185
    More Than One-Third Of Patients Reach Serum Urate Target and Continue To Report Multiple Flares
  • Abstract Number: 2673
    Mortality In Clinically Relevant Osteoarthritis and Rheumatoid Arthritis Compared With The General Population
  • Abstract Number: 2295
    Mortality In Early Rheumatoid Arthritis Comparing Lithuania and Finland. A 13-Year Follow Up
  • Abstract Number: 2059
    Mortality In Polymyositis and Dermatomyositis: A Single Centre Study
  • Abstract Number: 2778
    Mortality In United States Veterans With The HLA-B27 Gene
  • Abstract Number: 2033
    Mortality Prognostic Factors Of Patients With Systemic Autoimmune Diseases Admitted To An Intensive Care Unit
  • Abstract Number: 781
    Mortality Rates, Readmissions and Revascularisation Following a First Myocardial Infarction In Patients With Autoimmune Rheumatic Disease Compared With Controls
  • Abstract Number: 2917
    Mortality, Recurrence, and Hospital Course of Patients With Systemic Sclerosis Related Acute Intestinal Pseudo-Obstruction
  • Abstract Number: 2261
    Motivations For Inadequate Persistence With Disease Modifying Anti-Rheumatic Drugs In Early Rheumatoid Arthritis: The Patient’s Perspective
  • Abstract Number: 2663
    Moving Towards Personalized Healthcare: A Patient Reported Outcome Based Algorithm Can Aid Rheumatologists and Patients In Monitoring Rheumatoid Arthritis In Daily Clinical Practice
  • Abstract Number: 1136
    MR T1ρ and T2 Of Meniscus After Acute Anterior Cruciate Ligament Injuries
  • Abstract Number: 288
    MRI Findings In Juvenile Spondyloarthopathy and Effects Of Treatment On Subsequent MRI
  • Abstract Number: 2511
    Multicenter Validation Of The Lupus Activity Scoring Tool (LAST) As Compared To The Selena Sledai (SS) Modification
  • Abstract Number: 510
    Multicentric Analysis Of Inter and Intra Observer Reliabilities For Histopathological Abnormalities In Salivary Gland Biopsy In Primary Sjögren Syndrome
  • Abstract Number: 635
    Multiple Altered Soluble Inflammatory Mediators Correlate With Disease Activity and Mark Impending Disease Flare In European-American Lupus Patients
  • Abstract Number: 1459
    Multiple Cytokine Profiling Predicts The Effectiveness Of Switching Biologics In Rheumatoid Arthritis
  • Abstract Number: 1388
    Multiplex Cytokine Analyses In Patients With Rheumatoid Arthritis Require Use Of Agents Blocking Heterophilic Antibody Activity
  • Abstract Number: 2561
    Multiplex Cytokine Analysis Of Dermal Interstitial Blister Fluid In Systemic Sclerosis Defines Potential Pathogenic Pathways and Differentiates Clinical Subsets
  • Abstract Number: 88
    Musculoskeletal Diseases Have The Worst Impact On Physical Health Compared With Other Diseases – Results Of The Dutch cross-Sectional Study
  • Abstract Number: 1043
    Musculoskeletal Hospital Admissions Among Patients Treated For Rheumatoid Arthritis Between 1999 and 2010 Compared With The General Population In The Netherlands
  • Abstract Number: 2135
    Musculoskeletal Pain Explains Differences In Function At Time Of Surgery In Black TKR and THR Patients
  • Abstract Number: 604
    Mycophenolate Mofetil Is Not Associated With Reduced Cardiovascular Or Lupus Damage Accumulation In a Cross-Sectional Lupus Cohort Study
  • Abstract Number: 955
    Myeloid Deletion Of SIRT1 Aggravates Serum Transfer Arthritis But Ameliorate Collagen-Induced Arthritis
  • Abstract Number: 100
    Myocardial Infarction and Mortality after Joint Surgery in Patients with Rheumatoid Arthritis Compared with the General Population
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences